While earlier studies reported impaired and limited response of type I interferons (IFN-I) (i.e., IFNα1, IFNβ) in response to COVID19, there is now increased evidence for robust IFN-I responses in patients with severe COVID19. This evidence concerns the gene IFNB1 and COVID-19.